Live Breaking News & Updates on Markus manns

Stay informed with the latest breaking news from Markus manns on our comprehensive webpage. Get up-to-the-minute updates on local events, politics, business, entertainment, and more. Our dedicated team of journalists delivers timely and reliable news, ensuring you're always in the know. Discover firsthand accounts, expert analysis, and exclusive interviews, all in one convenient destination. Don't miss a beat — visit our webpage for real-time breaking news in Markus manns and stay connected to the pulse of your community

Novo Nordisk raises outlook fuelled by obesity drug demand By Reuters

Novo Nordisk raises outlook fuelled by obesity drug demand By Reuters
investing.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from investing.com Daily Mail and Mail on Sunday newspapers.

Germany , United-states , Denmark , Poland , London , City-of , United-kingdom , Danish , Britain , Eli-lilly , Lars-fruergaard-jorgensen , Karsten-munk-knudsen

Novo Nordisk raises 2024 outlook as company races to boost output of Wegovy weight-loss drug

Novo Nordisk reported better-than-expected first-quarter profits on Thursday as it looks to fend off competition from rival Eli Lilly

United-states , Denmark , Canada , Poland , Spain , Germany , United-kingdom , Britain , Danish , Eli-lilly , Karsten-munk-knudsen , Markus-manns

Novo Nordisk lifts 2024 outlook on weight-loss drug demand

Danish pharma giant Novo Nordisk lifted its 2024 outlook on Thursday and delivered better-than-expected first quarter profits as the company races to boost...

United-states , Poland , United-kingdom , Germany , Denmark , Britain , Danish , Eli-lilly , Lars-fruergaard-jorgensen , Markus-manns , Karsten-munk-knudsen , Union-investment

Health: Blockbuster obesity drug demand drives Novo Nordisk profit boost

Health: Blockbuster obesity drug demand drives Novo Nordisk profit boost
gdnonline.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from gdnonline.com Daily Mail and Mail on Sunday newspapers.

United-states , United-kingdom , Poland , Copenhagen , Køavn- , Denmark , Spain , Germany , Canada , Britain , Danish , Lars-fruergaard-jorgensen

Bayer investors weigh need for cash call amid stifling debt

Bayer may have
to ask shareholders for fresh capital to shore up its finances
even after the debt-laden German drugmaker slashed dividends
last week in its latest effort to get wiggle room,...

Germany , Switzerland , German , Swiss , Markus-manns , Julius-baer , Josephine-mason , Fabian-wenner , Bill-anderson , Martin-schnee , Ludwig-burger , Christina-fincher

Analysis-Bayer investors weigh need for cash call amid stifling debt

Bayer may have to ask shareholders for fresh capital to shore up its finances even after the debt-laden German drugmaker slashed dividends last week in its latest effort to get wiggle room, analysts said. But new CEO Bill Anderson may struggle to win over investors, who have seen the company's value sink by two thirds since its $63 billion acquisition of Monsanto in 2018, which saddled it with costly litigation and debt. The debate over a possible share issue comes as Anderson, who was hired last June to revive the company's fortunes, prepares to deliver a strategic investor update in London on Tuesday.

Switzerland , Germany , Swiss , German , Christina-fincher , Patricia-weiss , Werner-baumann , Martin-schnee , Bill-anderson , Ludwig-burger , Josephine-mason , Fabian-wenner

Novo Nordisk sees double-digit FY growth; boosts Wegovy supplies to U.S By Reuters

Novo Nordisk sees double-digit FY growth; boosts Wegovy supplies to U.S By Reuters
investing.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from investing.com Daily Mail and Mail on Sunday newspapers.

United-states , Denmark , Copenhagen , Køavn- , Danish , Lars-fruergaard-jorgensen , Markus-manns , Reuters , Union-investment , Novo-nordisk , Fruergaard-jorgensen , Eli-lilly

Novo Nordisk doesn't disappoint

The Danish laboratory anticipates another year of robust double-digit growth in sales and operating profit, while beginning to ease restrictions on the supply of its popular weight loss drug, Wegovy....

United-states , Denmark , Markus-manns , Lars-fruergaard-jorgensen , Eli-lilly , Novo-nordisk , Union-investment , Fruergaard-jorgensen , Markets ,

As Roundup verdicts pile up, Bayer bets big on US appeals courts

Despite more than $4 billion in U.S.
jury verdicts over Bayer's Roundup weedkiller,
including a $2.25 billion verdict last week, the company so far
has shown no willingness to settle, instead betting...

California , United-states , Missouri , Pennsylvania , Germany , New-york , German , Alexia-garamfalvi , Markus-manns , Brendan-pierson , David-noll , John-mckivison

Analysis-As Roundup verdicts pile up, Bayer bets big on US appeals courts

Despite more than $4 billion in U.S. jury verdicts over Bayer's Roundup weedkiller, including a $2.25 billion verdict last week, the company so far has shown no willingness to settle, instead betting that it can greatly reduce, or wipe out, its liability through legal appeals. The strategy means the German pharmaceutical and biotechnology company could face further trials and hefty verdicts for years to come as its appeals work their way through U.S. courts. At least 10 trials are expected this year in state courts around the United States, and close to 50,000 Roundup lawsuits are currently pending.

California , United-states , Missouri , New-york , Germany , Pennsylvania , German , Markus-manns , David-noll , Amy-stevens , Brendan-pierson , Alexia-garamfalvi